Core Scientific, Inc. (CORZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	440.3M	319.0M	510.7M	502.4M	640.3M
Cost of Revenue	316.0M	281.1M	389.6M	378.9M	631.9M
Gross Profit	124.5M	37.9M	121.1M	123.5M	8.4M
Operating Expenses
R&D Expense	—	—	11.8M	7.2M	27.0M
SG&A Expense	207.1M	182.6M	120.4M	100.9M	226.0M
General & Admin Expense	—	182.6M	110.4M	93.9M	213.3M
Selling & Marketing Expense	—	—	10.0M	7.0M	12.7M
Other Expenses	65.7M	79.9M	8.0M	6.4M	1.9B
Total Operating Expenses	272.8M	262.4M	140.3M	114.5M	2.1B
Cost and Expenses	588.6M	543.6M	529.9M	493.4M	2.7B
Operating Income (EBIT)	(148.3M)	(224.6M)	(19.2M)	9.0M	(2.1B)
Non-Operating
Interest Income	821.0K	3.3M	—	—	—
Interest Expense	29.6M	—	37.1M	86.2M	96.8M
Net Interest Income	(28.8M)	3.3M	(37.1M)	(86.2M)	(96.8M)
Other Non-Op Income/Expense	(1.3B)	(63.5M)	(1.3B)	(254.8M)	(53.9M)
Non-Operating Income (excl Interest)	1.3B	63.5M	1.3B	168.5M	(43.0M)
EBT (Pre-Tax Income)	(1.4B)	(288.0M)	(1.3B)	(245.8M)	(2.2B)
Income Tax Expense	2.7M	583.0K	859.0K	683.0K	(17.1M)
Bottom Line
Net Income	(1.4B)	(288.6M)	(1.3B)	(246.5M)	(2.1B)
Earnings from Cont. Ops	(1.4B)	(288.6M)	(1.3B)	(246.5M)	(2.1B)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(1.4B)	(288.6M)	(1.3B)	(246.5M)	(2.1B)
Per Share
Basic EPS	($4.17)	($0.88)	($5.14)	($0.65)	($6.30)
Diluted EPS	($4.17)	($0.88)	($5.14)	($0.65)	($6.30)
Revenue Per Share	$1.35	$1.00	$2.00	$1.32	$1.88
Shares
Basic Shares Outstanding	325.3M	318.1M	255.8M	379.9M	340.6M
Diluted Shares Outstanding	325.3M	318.1M	255.8M	379.9M	340.6M
Profitability Metrics
EBITDA	(1.3B)	(207.9M)	(1.2B)	(63.1M)	(1.8B)
D&A	60.2M	80.2M	120.1M	96.4M	226.1M
EBIT	(1.4B)	(288.0M)	(1.3B)	(159.6M)	(2.1B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026